Literature DB >> 818786

The role of prolactin in the development of chronic progressive nephropathy in the rat.

B Richardson, H Luginbühl.   

Abstract

Prolactin as a factor in the etiology of chronic progressive nephropathy in rats has been studied by exogenous administration and by endogenous inhibition with bromocriptin. Exogenous prolactin caused a significant increase in frequency and severity of the lesions, with accompanying sodium retention. Conversely endogenous inhibition significantly decreased the frequency and severity of the lesions and increased urine volume, pH and sodium excretion. Thus prolactin is important in the etiology of this renal disease in rats.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 818786     DOI： 10.1007/BF00427307

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histol        ISSN： 0340-1227


  14 in total

1.  Senile changes in the kidneys of Wistar Institute rats.

Authors:  W ANDREW; D PRUETT
Journal:  Am J Anat       Date:  1957-01

2.  Dependent and autonomous mammotropic pituitary tumors in rats; their somatotropic features.

Authors:  R F BUFFETT; K H CLIFTON; J FURTH; E L GADSDEN
Journal:  Cancer Res       Date:  1956-08       Impact factor: 12.701

3.  Autonomous mammotropic pituitary tumors in mice; their somatotropic features and responsiveness to estrogens.

Authors:  E ANDERSON; K H CLIFTON; J FURTH; E L GADSDEN
Journal:  Cancer Res       Date:  1956-08       Impact factor: 12.701

4.  Phaeochromocytoma in the rat; pathogenesis and collateral reactions and its relation to comparable tumours in man.

Authors:  J GILLMAN; C GILBERT; I SPENCE
Journal:  Cancer       Date:  1953-05       Impact factor: 6.860

5.  Endocrine profile of a specific prolactin inhibitor: Br-ergocryptine (CB 154). A preliminary report.

Authors:  E Del Pozo; H Friesen; P Burmeister
Journal:  Schweiz Med Wochenschr       Date:  1973-06-09

Review 6.  Human prolactin. An ancient molecule provides new insights for clinical medicine.

Authors:  R W Turkington
Journal:  Am J Med       Date:  1972-10       Impact factor: 4.965

7.  Actions of prolactin on human renal function.

Authors:  D F Horrobin; I J Lloyd; A Lipton; P G Burstyn; N Durkin; K L Muiruri
Journal:  Lancet       Date:  1971-08-14       Impact factor: 79.321

8.  Gynecomastia, prolactin, and other peptide hormones in patients undergoing chronic hemodialysis.

Authors:  T C Nagel; N Freinkel; R H Bell; H Friesen; J F Wilber; B E Metzger
Journal:  J Clin Endocrinol Metab       Date:  1973-03       Impact factor: 5.958

9.  Evidence for a luteolytic function of prolactin in the intact cyclic rat using 2-Br-alpha-Ergokryptine (CB 154).

Authors:  E Billeter; E Flückinger
Journal:  Experientia       Date:  1971-04-15

10.  Circadian periodicity of serum prolactin concentration in man.

Authors:  J Nokin; M Vekemans; M L'Hermite; C Robyn
Journal:  Br Med J       Date:  1972-09-02
View more
  2 in total

1.  Renal and vascular activity of prolactin preparations. Contamination of prolactin preparations with ADH and implications on renal and vascular prolactin research.

Authors:  H Vorherr
Journal:  Klin Wochenschr       Date:  1979-02-01

Review 2.  Toxicological evaluation of cyclosporin A.

Authors:  B Ryffel; P Donatsch; M Madörin; B E Matter; G Rüttimann; H Schön; R Stoll; J Wilson
Journal:  Arch Toxicol       Date:  1983-06       Impact factor: 5.153
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.